Diseases generally indicated for Kampo extract preparations containing Gardenia jasminoides (Sanshishi)
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who visited Shinshu University Hospital between April 1, 2017, and March 31, 2025, and were prescribed Kampo extract preparations in the outpatient clinic.
Exclusion criteria
Exclusion criteria: None.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of patients prescribed Gardenia-containing Kampo extract preparations among all patients who were prescribed Kampo formulations during the data collection period, the breakdown of Gardenia-containing Kampo preparations, and the estimated cumulative dose of Gardenia jasminoides (Sanshishi). | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient background (department, current medical history, and past medical history) of patients prescribed Gardenia-containing Kampo extract preparations among all patients who were prescribed Kampo formulations during the data collection period. | — |
Countries
Japan
Contacts
Shinshu University School of Medicine Department of Anesthesiology and Resuscitology